Regeneron Pharmaceuticals
The latest news about Regeneron Pharmaceuticals: headlines, AI summaries and the full story from every source.
- Regeneron's Future May Depend on Dupixent Amid Eylea Sales Decline
- Regeneron Reports Mixed Results in Ovarian Cancer Therapy Trial
- Class Action Lawsuit Filed Against Regeneron Pharmaceuticals Over Alleged Misleading Statements
- Regeneron's FDA Approved Gene Therapy for Hearing Loss Amid Mixed Financial Results
- TD Cowen Increases Price Target for Regeneron Pharmaceuticals Ahead of Fiscal Q1 Results